COMMUNIQUÉS West-GlobeNewswire

MiNK Therapeutics to Present iNKT Cell Therapy in Gastric Cancer at ASCO GI Annual Meeting

18/12/2024 - 15:45

Presentation will feature the ongoing Phase 2 study of agenT-797 in refractory gastric cancer NEW YORK, Dec. 18, 2024 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical [...]

Orion and Abilita Therapeutics announce research collaboration and option to license agreement to develop innovative antibody therapeutics

18/12/2024 - 16:00

ORION CORPORATION PRESS RELEASE 18 DECEMBER 2024 at 17.00 EET Orion and Abilita Therapeutics announce research collaboration and option to license agreement to develop innovative antibody therapeutics Orion Corporation [...]

Olympia Pharmaceuticals Announces the Launch of Sister Brand, Wesley Pharmaceuticals, in Honor of Beloved Employee

18/12/2024 - 16:05

The first location will serve as a new production facility for the company, tripling current production capacity ORLANDO, Fla., Dec. 18, 2024 (GLOBE NEWSWIRE) -- Olympia Pharmaceuticals , a leading innovator in the [...]

TigaTx Announces up to $35.5M in Funding from ARPA-H and NIH Awards to Advance First-in-Class Engineered IgA Monoclonal Antibody for Cancer and Infectious Diseases

18/12/2024 - 16:05

TigaTx will use the ARPA-H and NIH funding to progress its lead program, TIGA-001, an IgA anti-EGFR neutrophil engager, into the clinic and generate clinical proof-of-concept data for its engineered IgA platform TigaTx [...]

Public Mental Health Plans Sue State Over Broken Negotiations

18/12/2024 - 16:23

Legal Action Seeks to Protect Services and Secure Fair Contract Terms LANSING, Mich., Dec. 18, 2024 (GLOBE NEWSWIRE) -- Michigan’s public mental health plans, known as Prepaid Inpatient Health Plans (PIHPs), have filed [...]

Trinity Biotech Receives Early Approval from the World Health Organization to Begin Offshore Manufacturing of TrinScreen HIV & Uni-Gold HIV

18/12/2024 - 17:00

DUBLIN, Ireland, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable [...]

The Ensign Group Agrees to Add Its First Operations in Alaska and Oregon And Announces Expansion in Washington and California

18/12/2024 - 12:00

SAN JUAN CAPISTRANO, Calif., Dec. 18, 2024 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living [...]

Vireo Growth Inc. Announces $75 Million Financing and Acquisitions of Four Single State Operators

18/12/2024 - 12:00

– $75 million equity financing at $0.625 per Vireo share will result in combined new entity having an industry-leading balance sheet – – Transactions would expand Vireo’s operating footprint to 7 states, 9 cultivation [...]

Polyrizon's Moving Forward with Expected 2025 Clinical Trial - Entered Manufacturing Agreement for its PL-14 Allergy Blocker

18/12/2024 - 12:25

The engagement with an EU-based GMP manufacturing facility enables timely production and preparation for clinical trial. The EU-based GMP manufacturer has large-scale commercial production capabilities, to support [...]

Tessera Therapeutics Receives Investment to Develop Curative In Vivo Genetic Treatment for Sickle Cell Disease

18/12/2024 - 12:30

Investments of up to $50 million from the Bill & Melinda Gates Foundation to develop globally accessible in vivo genetic therapies for sickle cell disease SOMERVILLE, Mass., Dec. 18, 2024 (GLOBE NEWSWIRE) -- Tessera [...]

Positive results advance peanut tablet to phase II development

18/12/2024 - 12:51

ALK’s peanut tablet shown to be safe and tolerable across multiple doses. Development now advances to phase II for dose finding and efficacy. First patients in phase II to receive first doses imminently. Trial expected [...]

MannKind Corporation Announces Exchange of Convertible Notes for Stock and Cash

18/12/2024 - 13:00

Company debt reduced by $194 million Cash position after closing will be in excess of $180 million DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Dec. 18, 2024 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) today [...]

Redecan Cannabis Launches New Limited-Edition Genetics and Expands Signature 'Wrapped & Redee' Pre-roll Line for the Holidays

18/12/2024 - 13:00

TORONTO, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Redecan Cannabis , a leading brand under Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), a leading global lifestyle and consumer packaged goods company, is thrilled to announce [...]

Cara Therapeutics and Tvardi Therapeutics Announce Entry into Merger Agreement

18/12/2024 - 13:00

Proposed Merger to create a Nasdaq-listed, clinical-stage biopharmaceutical company developing novel treatments targeting STAT3 to treat fibrosis-driven diseases Tvardi has recently completed an approximately $28 [...]

European Commission Adopts Positive Decision for Orphan Medicinal Product Designation of Agios’ Mitapivat in Sickle Cell Disease

18/12/2024 - 13:00

CAMBRIDGE, Mass., Dec. 18, 2024 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and pyruvate kinase (PK) activation pioneering therapies for rare diseases, today announced [...]

Oruka Therapeutics to be Added to the Nasdaq Biotechnology Index (NBI)

18/12/2024 - 13:00

MENLO PARK, Calif., Dec. 18, 2024 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a biotechnology company developing novel biologics designed to set a new standard for the treatment of chronic [...]

Entrada Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

18/12/2024 - 13:00

BOSTON, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (Nasdaq: TRDA) is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that [...]

NMD Pharma publishes new data on the role of ClC-1 inhibition in Charcot-Marie-Tooth in the Annals of Clinical and Translational Neurology

18/12/2024 - 13:00

NMD Pharma publishes new data on the role of ClC-1 inhibition in Charcot-Marie-Tooth in the Annals of Clinical and Translational Neurology Results from the ESTABLISH 1 observational study confirms that neuromuscular [...]

Cartesian Therapeutics Announces New Employment Inducement Grants

18/12/2024 - 13:05

FREDERICK, Md., Dec. 18, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell therapies for the treatment of autoimmune [...]